- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (
Total 435556 results
-
Centre Francois BaclesseNational Cancer Institute, France; ARC Foundation for Cancer ResearchTerminatedMetastatic Breast Cancer | PostmenopausalFrance
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Israel, Taiwan, Argentina, Japan, Korea, Republic of, Canada, Australia, Brazil
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Novartis PharmaceuticalsCompleted
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States
-
AmgenAustrian Breast and Colorectal Cancer Study GroupCompletedBreast CancerAustria, Sweden
-
PfizerActive, not recruitingBreast NeoplasmsChina, Taiwan, Hong Kong, Singapore, Thailand
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Canada, France, Italy, Spain, Taiwan, Hungary, Turkey, Belgium, Germany, Netherlands, Singapore, Austria, Czechia, Australia, Israel, Russian Federation, Sweden, United Kingdom, Korea, Republic of, Thailand, Lebanon, ... and more
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
Novartis PharmaceuticalsCompleted
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
iOMEDICO AGNovartis Pharmaceuticals; Arbeitsgemeinschaft fur Internistische OnkologieCompletedBreast Cancer Recurrent | HER2/Neu-negative Carcinoma of Breast | Hormone Receptor Positive Malignant Neoplasm of BreastGermany
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
AstraZenecaTerminatedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Czech Republic, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, United Kingdom, Philippines, Ukraine, Finland, Canada, Taiwan, India, Thailand, United States, Japan
-
Technical University of MunichWithdrawn
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
PfizerCompleted
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, China, Spain, Hungary, Japan, Australia, Brazil, Italy, Slovakia, Switzerland
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
International Cancer Research Group, United Arab...King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaboratorsRecruitingHormonal Receptors Positive, HER2 Negative, Advanced Breast CancerAlgeria, Jordan, Saudi Arabia
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Lund University HospitalSouth Sweden Breast Cancer GroupRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast CarcinomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, China, Denmark, France, Hungary, Portugal, Spain, Taiwan, Thailand, Italy, Argentina, Brazil, Poland, Singapore, Germany, Greece, Hong Kong, Ukraine, Russian... and more
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Taiwan, Canada, Germany, Argentina, Israel, Korea, Republic of, Denmark, France, India, Chile, Netherlands, Singapore, Japan, Mexico
-
PfizerActive, not recruiting
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Novartis PharmaceuticalsActive, not recruiting
-
Novartis PharmaceuticalsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | HER2-positive Breast Cancer | Advanced Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, Peru and more
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, Italy, Spain, United Kingdom, Austria, Czechia, Hungary, Malaysia, Saudi Arabia, Taiwan, Argentina, France, Israel, Netherlands, Russian Federation, Hong Kong, Thailand, Lebanon, Bulgaria, Denmark, Po... and more